As a final example, the goal of improving access to medicines no longer aims mainly to match essential medicines with priority needs and ensure affordability.

However, according to Chinese medicines for introduction of Chinese research group, lower prices of patented drugs, to improve drug availability in China, progress is not smooth.

Improved drug access without significant improvements in appropriate use will have dire consequences, with continued emergence of "superbugs" and untreatable infections.